Mirion Technologies (MIR) AI Stock Analysis

• Market Cap: $3.93B
• Dividend Yield: N/A
• Average Volume (3M): 1.63M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.59
• Revenue Growth: 7.25%
• EPS Growth: 87.34%
• Country: US
• Employees: 2,800
• Sector: Industrials
• Sector Strength: 83
• Industry: Industrial - Machinery
• EPS (TTM): 0.10
• Shares Outstanding: 225,554,630
• 10 Day Avg. Volume: 1,820,649
• 30 Day Avg. Volume: 1,629,537
• PEG Ratio: -0.10
• Price to Book (P/B): 2.37
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 43.88
• Enterprise Value/Market Cap: 1.08
• Enterprise Value/Revenue: 1.25
• Enterprise Value/Gross Profit: 9.71
• Enterprise Value/Ebitda: 11.02
• 1Y Price Target: $18.75
• Price Target Upside: 10.62% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

Mirion Technologies presents a solid growth trajectory with strong revenue growth, improved margins, and reduced debt, enhancing its financial stability. Positive technical indicators and strong earnings call highlights reinforce a favorable outlook. However, the negative P/E ratio and challenges in achieving consistent profitability temper the score, with strategic initiatives and market opportunities offering potential for future improvement.

Positive Factors

Demand Trends

Favorable demand drivers and MIR’s strong position within its end markets could be durable growth drivers.

M&A Activity

Management noted reduced net leverage at 2.5x and indicated a 'very strong' M&A pipeline, viewing acquisition-oriented capital deployment as likely to accelerate.

Nuclear Energy Demand

Nuclear power generation could continue to be viewed increasingly favorably, driving solid underlying demand for MIR’s commercial nuclear business.

Negative Factors

Debt Levels

Reduced debt leverage has improved M&A optionality; successful M&A history/platform.

Market Competition

The Nuclear Regulatory Commission's mission statement supports the growth of civilian nuclear energy technologies, benefiting companies like Mirion Technologies.

Operational Challenges

An increased focus on operational execution and continuous improvement is contributing to ongoing margin expansion potential.

Mirion Technologies Business Overview & Revenue Model

Company Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

How the Company Makes Money

Mirion Technologies generates revenue through the sale of its radiation detection, measurement, and monitoring products and services. Key revenue streams include sales of radiation monitoring equipment to nuclear power plants and government agencies, dosimetry services for medical and industrial applications, and the provision of safety and training solutions for military and homeland security sectors. The company benefits significantly from long-term contracts and partnerships with governmental and private entities seeking compliance with safety regulations and enhanced operational safety in radiation-prone environments.

Mirion Technologies Financial Statement Overview

Summary

Mirion Technologies demonstrates robust revenue growth and improved gross profit margins. Debt reduction and equity strengthening indicate enhanced financial stability. Despite these strengths, the company faces ongoing challenges with achieving consistent profitability.

Income Statement

Mirion Technologies shows a consistent revenue growth trajectory, increasing from $322.1 million in 2021 to $870.2 million in the TTM, indicating strong market demand. Gross profit margin has improved to 50% in the TTM, suggesting effective cost management. However, the net profit margin remains negative, indicating ongoing challenges in achieving profitability. EBIT and EBITDA margins show signs of recovery, but further improvements are needed to ensure sustainable profitability.

Balance Sheet

The company's balance sheet displays improving financial health with a reduction in total debt from $1,698 million in 2020 to $33.6 million in the TTM. The debt-to-equity ratio has significantly improved, reflecting reduced leverage. Stockholders' equity has turned positive, indicating a stronger equity base. However, the equity ratio remains moderate, and further strengthening of the equity position is recommended.

Cash Flow

Mirion Technologies shows strong cash flow management with positive operating and free cash flows in the TTM. The operating cash flow to net income ratio is robust, indicating effective cash generation relative to earnings. Free cash flow has grown substantially, highlighting efficient capital expenditure management. These factors suggest good liquidity and operational efficiency.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
870.20M	860.80M	800.90M	717.80M	322.10M	478.20M
	Gross Profit
435.40M	399.70M	356.40M	317.20M	81.10M	197.00M
	EBIT
38.40M	24.80M	-21.90M	266.90M	-61.60M	-1.37M
	EBITDA
41.10M	174.40M	114.30M	-90.80M	-19.20M	22.88M
	Net Income Common Stockholders
-10.00M	-36.10M	-96.90M	-324.80M	-127.90M	-1.04M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
126.00M	181.10M	134.10M	77.80M	84.00M	383.25K
	Total Assets
2.65B	2.64B	2.72B	2.74B	3.12B	751.32M
	Total Debt
718.70M	719.90M	721.00M	849.60M	860.60M	1.70B
	Net Debt
598.10M	544.70M	592.20M	776.10M	776.60M	1.70B
	Total Liabilities
1.13B	1.08B	1.17B	1.27B	1.33B	27.59M
	Stockholders Equity
1.46B	1.56B	1.48B	-408.50M	1.69B	723.72M
Cash Flow		Free Cash Flow
84.20M	50.30M	58.10M	5.20M	-16.70M	-20.85M
	Operating Cash Flow
128.70M	99.10M	95.20M	39.40M	900.00K	-945.35K
	Investing Cash Flow
-38.40M	-43.70M	-64.70M	-40.80M	-2.20B	-75.60M
	Financing Cash Flow
-24.70M	-3.30M	22.60M	-7.00M	1.54B	751.39M

Mirion Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 16.95
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MIR, the sentiment is Positive. The current price of 16.95 is above the 20-day moving average (MA) of 15.36, above the 50-day MA of 14.77, and above the 200-day MA of 14.29, indicating a bullish trend. The MACD of 0.65 indicates Negative momentum. The RSI at 74.24 is Negative, neither overbought nor oversold. The STOCH value of 89.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MIR.

Mirion Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MWA	76 Outperform	$3.98B	27.75	17.68%	1.07%	10.96%	43.44%
MIR	71 Outperform	$3.93B	―	-0.68%	―	7.25%	87.34%
FELE	71 Outperform	$4.09B	23.45	14.11%	1.17%	-1.26%	-4.84%
KAI	71 Outperform	$3.77B	33.99	13.38%	0.41%	6.83%	-1.84%
Sector *	64 Neutral	$4.36B	12.05	5.23%	249.94%	4.13%	-10.23%
NPO	64 Neutral	$3.83B	45.33	5.90%	0.69%	2.92%	―
CXT	59 Neutral	$3.17B	19.02	16.23%	1.18%	9.28%	-8.45%

Mirion Technologies Corporate Events

Mirion Technologies Sets Ambitious Growth and Strategic Plans

Mirion Technologies is poised for growth as it unveils its ambitious 2028 financial outlook and initial 2025 guidance, alongside a strategic partnership with Electronics Corporation of India Ltd to boost India’s nuclear sector. The company plans a $100 million share repurchase program to enhance shareholder value and maintain capital flexibility, while navigating opportunities in the growing nuclear and cancer care markets. Mirion’s leadership emphasizes its unique positioning to leverage market tailwinds, aiming for robust growth and operational excellence.